In GBM and other cancers, pro-angiogenic signaling molecules, including basic fibroblast growth factor (bFGF) and vascular endothelial growth factor A (VEGF-A), are secreted by stromal cells and tumor cells. This evidence concerns the gene FGF2 and glioblastoma.